Myocardial lnfarction in newly diagnosed hypertensive medicaid patients free of coronary heart disease and treated with calcium channel blockers

American Journal of Medicine

Volumn 102, Issue 2, 1997, Pages 150-156

  Leader, Shelah G ^a   Mallick, Rajiv ^a   Briggs, Nathaniel C ^a  

^a Pracon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE; AMLODIPINE BESYLATE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INDAPAMIDE; ISRADIPINE; LISINOPRIL; METOPROLOL TARTRATE; NIFEDIPINE; TRIAMTERENE; VASODILATOR AGENT; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIURETIC THERAPY; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT SELECTION; PRESCRIPTION; PRIORITY JOURNAL; ADOLESCENT; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; HEART INFARCTION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; CORONARY DISEASE; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICAID; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0030610009     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00403-2     Document Type: Article

References (16)

1. Psaty BM, et al. The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA. 1995;274:620-625.
2. Furberg C, et al. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
3. Pahor M, et al. Long term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc. 1995;43:1191-1197.
4. National Heart, Lung, and Blood Institute Statement. New Analyses Regarding the Safety of Calcium-Channel Blockers. Washington DC: National Heart, Lung and Blood Institute; September 1, 1995.
5. The Washington Post. January 26, 1996; A3.
6. Bright R, et al. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989;42:937-945.
7. Quam L, et al. Using claims data for epidemiologic research. Med Care. 1993;31:498-507.
8. Meehan TP, et al. Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut. Ann Intern Med. 1995;122:928-936.
9. Fowles JB, et al. Agreement between physicians office records and Medicare. Part B: claims data. Health Care Fin R. 1995;16:4189-199.
10. Braun S, et al. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11, 575 patients. J Am Coll Cardiol. 1996;28:7-11.
11. Jick H, et al. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential gypertension. Pharmacotherapy. 1996;16:321-326.
12. Gong L, et al. Shanghai Trial of Nifedipine in the Elderly (STONE). J Hypertens. 1996;14:1237-1245.
13. Wayne R, Griffin M. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129:837-849.
14. Gerstman BB, et al. A method of pharmacoepidemiologic analysis that uses computerized Medicaid. J Clin Epidemiol. 1990;43:1387-1393.
15. Fisher E, et al. Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Pub Health. 1990;80:1487-1490.
16. Anderson G, et al. Development of clinical and economic prognoses from Medicare claims data. JAMA. 1990;263:967-972.